The World Health Organization has been given the go-ahead by officials in the Democratic Republic of Congo to import and use an experimental Ebola vaccine in the country, the WHO Director-General, said today.
The director told reporters “We have agreement, registration, plus import permit, everything formally agreed already, all is ready now to really use it.”
According to Reuters News Agency, vaccinations could begin by next Monday.
The vaccine, developed by Merck in 2016, has proven safe and effective in human trials, but it is still experimental as it does not yet have a license.
It must be kept at -60 to -80 degrees Celsius, creating huge logistical challenges.
Taiwan National Day Celebration
